Blocking anti-Dkk-1 antibodies and their uses

Details for Australian Patent Application No. 2010246981 (hide)

Owner Pfizer Inc. Rinat Neuroscience Corporation

Inventors Li, Mei; Paralkar, Vishwas Madhav; Pons, Jaume; Stone, Donna Marie

Agent Shelston IP

Pub. Number AU-A-2010246981

PCT Pub. Number WO2010/131185

Priority 61/244,638 22.09.09 US; 61/177,650 12.05.09 US

Filing date 10 May 2010

Wipo publication date 18 November 2010

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

Event Publications

8 December 2011 PCT application entered the National Phase

  PCT publication WO2010/131185 Priority application(s): WO2010/131185

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010246984-Aerosol drug delivery apparatus and method

2010246959-Separation of Mg2+ ions from sea-and brackish water for the purpose of remineralization of water and wastewater